Jean-Luc M. Lemercier - Apr 8, 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Apr 8, 2022
Transactions value $
-$1,183,900
Form type
4
Date filed
4/11/2022, 07:03 PM
Previous filing
Mar 11, 2022
Next filing
May 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $254K +11.7K +7.65% $21.76 164K Apr 8, 2022 Direct F1
transaction EW Common Stock Sale -$12.4K -100 -0.06% $123.57 164K Apr 8, 2022 Direct F1
transaction EW Common Stock Sale -$1.43M -11.6K -7.05% $123.29 152K Apr 8, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -11.7K -50.22% $0.00 11.6K Apr 8, 2022 Common Stock 11.7K $21.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $122.57 to $123.55. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.